JP2014518377A5 - - Google Patents

Info

Publication number

JP2014518377A5

JP2014518377A5 JP2014513712A JP2014513712A JP2014518377A5 JP 2014518377 A5 JP2014518377 A5 JP 2014518377A5 JP 2014513712 A JP2014513712 A JP 2014513712A JP 2014513712 A JP2014513712 A JP 2014513712A JP 2014518377 A5 JP2014518377 A5 JP 2014518377A5

Authority

JP

Japan

Prior art keywords

patient

jcv

determined

vla

therapy

Prior art date

2012-05-31

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108090001123 antibodies Proteins 0.000 claims description 129
• 102000004965 antibodies Human genes 0.000 claims description 129
• 241000701460 JC polyomavirus Species 0.000 claims description 71
• 238000002560 therapeutic procedure Methods 0.000 claims description 71
• 206010036807 Progressive multifocal leukoencephalopathy Diseases 0.000 claims description 70
• 230000002401 inhibitory effect Effects 0.000 claims description 64
• 239000000523 sample Substances 0.000 claims description 61
• 239000012472 biological sample Substances 0.000 claims description 31
• 239000011541 reaction mixture Substances 0.000 claims description 24
• 239000003018 immunosuppressive agent Substances 0.000 claims description 20
• 239000000758 substrate Substances 0.000 claims description 19
• 238000004166 bioassay Methods 0.000 claims description 18
• 238000002650 immunosuppressive therapy Methods 0.000 claims description 10
• 108010035649 Natalizumab Proteins 0.000 claims description 9
• 229960005027 natalizumab Drugs 0.000 claims description 9
• 238000001514 detection method Methods 0.000 claims description 7
• 239000003153 chemical reaction reagent Substances 0.000 claims description 6
• 238000003018 immunoassay Methods 0.000 claims description 6
• 108010072051 Glatiramer Acetate Proteins 0.000 claims description 5
• 102000014150 Interferons Human genes 0.000 claims description 5
• 108010050904 Interferons Proteins 0.000 claims description 5
• FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 claims description 5
• 239000003246 corticosteroid Substances 0.000 claims description 5
• 229960003776 glatiramer acetate Drugs 0.000 claims description 5
• 229940079322 interferon Drugs 0.000 claims description 5
• 230000036462 Unbound Effects 0.000 claims description 4
• 230000000694 effects Effects 0.000 claims description 4
• 230000001861 immunosuppresant Effects 0.000 claims description 4
• 239000000427 antigen Substances 0.000 claims description 3
• 102000038129 antigens Human genes 0.000 claims description 3
• 108091007172 antigens Proteins 0.000 claims description 3
• 239000002245 particle Substances 0.000 claims description 3
• 238000002965 ELISA Methods 0.000 claims description 2
• 238000009175 antibody therapy Methods 0.000 claims description 2
• 239000003814 drug Substances 0.000 claims description 2
• 229940079593 drugs Drugs 0.000 claims description 2
• 150000007523 nucleic acids Chemical class 0.000 claims description 2
• 108020004707 nucleic acids Proteins 0.000 claims description 2
• 239000007787 solid Substances 0.000 claims description 2
• 238000011156 evaluation Methods 0.000 claims 2
• 108010008212 Integrin alpha4beta1 Proteins 0.000 claims 1
• 230000002596 correlated Effects 0.000 claims 1
• 230000036039 immunity Effects 0.000 claims 1
• 230000001629 suppression Effects 0.000 claims 1
• 239000000243 solution Substances 0.000 description 7
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 210000002966 Serum Anatomy 0.000 description 4
• UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
• 239000000463 material Substances 0.000 description 2
• YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-N,N-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
• 230000003247 decreasing Effects 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1